Thrombolytic agents for arterial and venous thromboses in neonates

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2005, Pages

  John, Cheri M ^a   Harkensee, Christian ^b  

^a WHISTON HOSPITAL   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ARTERY; FIBRINOLYTIC THERAPY; HUMAN; NEWBORN; REVIEW; THROMBOSIS; VEIN THROMBOSIS;

ARTERIES; FIBRINOLYTIC AGENTS; HUMANS; INFANT, NEWBORN; THROMBOLYTIC THERAPY; THROMBOSIS; VENOUS THROMBOSIS;

EID: 84921705776     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004342.pub2     Document Type: Review

References (28)

1. Anderson BJ, Keeley SR, Johnson ND. Caval thrombolysis in neonates using low doses of recombinant human tissue plasminogen activator. Anaesthia and Intensive Care 1991;19:22-7.
2. Cheah FC, Boo NY, Rohana J, Yong SC. Successful clot lysis using low dose of Streptokinase in 22 neonates with aortic thromboses. Journal of Paediatrics and Child Health 2001;37:479-82.
3. Ferrari F, Vagnarelli F, Gargano G, Roversi MF, Biagioni O, Ranzi A, Cavazzuti GB. Early intra-cardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator. Archives of Disease in Childhood. Fetal and Neonatal Edition 2001;85:F66-9.
4. Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thrombosis Research 2003;109:85-92.
5. Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thrombosis Research 2003;109:101-8.
6. Nowak-Gottl U, Kreuz WD, Schwabe D, et al. Thrombolysis with r-TPA in children suffering from arterial or venous thromboses [Thrombolyse mit rTPA bei Kindern mit arteriellen und venosen Thrombosen]. Klinische Padiatrie 1991;203:359-62.
7. Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, et al. Low-dose tissue plasminogen activator thrombolysis in children. Journal of Pediatric Hematology/Oncology 2003;25:379-86.
8. Andrew ME, Monagle P, de Veber G, Chan AK. Thromboembolic disease and antithrombotic therapy in newborns. Hematology (Am Soc Hematol Educ Program) 2001:358-74.
9. Blanchette V, Doyle J, Schmidt B, et al. Neonatal thrombosis and emboli. Pathophysiology and management of the newborn. Edited by Avery, Fletcher and Macdonald. 1994. Philadelphia: JB Lippincott, 1994.
10. Bosque E, Weaver L. Continuous versus intermittent heparin infusion of umbilical artery catheters in the newborn infant. Journal of Pediatrics 1986;108:141-3.
11. Caplan MS, Cohn RA, Langman CB, Conway JA, Shkolnik A, Brouillette RT. Favorable outcome of neonatal aortic thrombosis and renovascular hypertension. Journal of Pediatrics 1989;115:291-5.
12. David RJ, Merten DF, Anderson JC, Gross S. Prevention of umbilical artery catheter clots with heparinized infusates. Developmental Pharmacology and Therapeutics 1981;2:117-26.
13. Edstrom CS, Christensen RD. Evaluation and treatment of thrombosis in the neonatal intensive care unit. Clin Perinatol 2000;27:623-41.
14. Horgan MJ, Bartoletti A, Polansky S, Peters JC, Manning TJ, Lamont BM. Effect of heparin infusates in arterial umbilical artery catheters on frequency of thrombotic complications. Journal of Pediatrics 1987;111:774-8.
15. Hudson IRB, Gibson BES, Brownlie J, Holland BM, Turner TL, Webber RG. Increased concentration of D-dimers in newborn infants. Archivs of Disease in Childhood 1990;65:383-4.
16. Manco-Johnson M. Diagnosis and management of thromboses in the perinatal period. Seminars in Perinatology 1990;14:393-402.
17. Martindale. The complete drug reference. 2nd Edition. Vol. 1, Pharmaceutical Press, 1999.
18. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thrombo-embolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-7.
19. Nowak-Gottl U, Auberger K, Halimeh S, Junker R, Klinge J, Kreuz WD, et al. Thrombolysis in newborns and infants. Journal of Thrombosis and Haemostasis 1999;82:112-6.
20. Olinsky A, Aitken FG, Isdale, JM. Thrombus formation after umbilical arterial catheterisation. An angiographic study. South African Medical Journal 1975;49:1467-70.
21. Oppenheimer DA, Carroll BA, Garth KE. Ultrasonic detection of complications following umbilical arterial catheterization in the neonate. Radiology 1982;145:667-72.
22. Payne RM, Martin TC, Bower RJ, Carter CE. Management and follow-up of arterial thrombosis in the neonatal period. Journal of Pediatrics 1989;114:853-8.
23. Rajani K, Goetzman BW, Wennberg RP, Turner E, Abildgaard C. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications. Pediatrics 1979;63:552-6.
24. Schmidt B, Zipursky A. Thrombotic disease in newborn infants. Clinics in Perinatology 1984;11:461-88.
25. Schmidt B, Andrew M. Neonatal thrombotic disease - prevention, diagnosis and treatment. Journal of Pediatrics 1988;113:407-10.
26. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;96:939-43.
27. Seibert JJ, Taylor BJ, Williamson L, Williams BJ, Szabo JS, Corbitt SL. Sonographic detection of neonatal umbilical artery thrombosis: clinical correlation. American Journal of Roentgenology 1987;148:965-8.
28. Seibert JJ, Northington, FJ, Miers JF, Taylor BJ. Aortic thrombosis after umbilical artery catheterisation in neonates: prevalence of complications on long-term follow-up. American Journal of Roentgenology 1991;156:567-9.